NCT06018987 - A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 5, 2023

Primary Completion Date

February 3, 2025

Study Completion Date

February 3, 2025

Conditions

Nasolabial Folds

Interventions

OTHER

No-Treatment Control

Participants will not receive treatment for 6 months and then will be offered an optional delayed treatment of HAC 20L after completion of of Month 6 visit with an optional touch-up treatment offered 30 days after delayed treatment.

DEVICE

HAC 20L

Subdermal Injections

Trial Locations (10)

13627

CRS Clinical Research Services Berlin GmbH /ID# 240390, Berlin

15831

Dermatologische Gemeinschaftspraxis Mahlow /ID# 232366, Blankenfelde-Mahlow

20146

Universitaet Hamburg /ID# 231641, Hamburg

34117

Noahklinik GmbH /ID# 231917, Kassel

40212

Privatpraxis Dr. Hilton & Partner /ID# 231401, Düsseldorf

40545

Dermatologie am Luegplatz /ID# 233788, Düsseldorf

50996

Hautzentrum Koeln /ID# 231406, Cologne

61440

MediCorium Zentrum fuer Dermatologie und Aesthetik /ID# 231403, Oberursel

80333

Hautok and Hautok-cosmetics /ID# 254549, Munich

80539

Privatpraxis fuer Dermatologie und Aesthetik /ID# 231402, München